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INTRODUCTION
Parkinson’s disease is a neurological disorder that in-
volves the degeneration of dopaminergic neurons in the 
substantia nigra. It is relatively common, affecting ap-
proximately 1% of the population over 60 years of age, 
and is characterized by motor symptoms such as tremor, 
rigidity, bradykinesia and postural instability. Of these, 
postural instability such as camptocormia is one of the 
most common symptoms, observed in 3%–17% of all Par-
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Objective  To investigate the effect of a conservative treatment regime in Parkinson’s disease patients with 
camptocormia.
Methods  Nine patients with Parkinson’s disease were included in a retrospective pilot study of the value of back 
extensor strengthening exercise. Six inpatients received a 30-minute treatment, twice daily for 5 weeks, being 
treated on average for 34 days; while three outpatients visited the clinic and were educated for home exercise 
and backpack wearing treatment. Outpatients should be scheduled to visit the outpatient department to check 
physical status every 2–4 weeks for an average of 3 months.
Results  All patients except one showed statistically significant improvements in activities of daily living (ADL) 
and motor symptoms, as measured by flexion angle at standing posture, Unified Parkinson’s Disease Rating Scale 
(UPDRS) II and III, and modified Hoehn-Yahr staging.
Conclusion  Conservative treatment is effective in postural correction of camptocormia in Parkinson’s disease, as 
well as improvement in ADL and motor symptoms.
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kinson’s disease patients [1-8].
Camptocormia is an axial postural deformity character-
ized by abnormal spinal flexion. It differs from kyphosis 
in that the kyphotic deformity can be corrected by lying 
down in a recumbent position, use of a high frame walk-
er, or standing against a wall [3]. The pathophysiology of 
camptocormia is not defined yet, but several hypotheses 
have been proposed; it may be a symptom of Parkinson’s 
disease progression, a form of dystonia in the course of 
Parkinson’s disease, a result of paraspinal myopathy that 
either follows or coincides with Parkinson’s disease, or a 
side effect of the medications used in Parkinson’s disease 
[4]. In addition, spinal deformity of this kind is difficult 
to distinguish from other axial skeletal disorders that are 
common in the elderly. Currently, there is no gold stan-
dard treatment available, with only a few case reports of 
pharmacological, surgical, and conservative treatment 
options. Conservative options include plaster corset, low-
slung backpack, high-frame walker with forearm sup-
port, thoraco-pelvic anterior distraction orthosis, taping, 
and physiotherapy—treatments. Previously, we reported 
a case study of effective correction of camptocormia by 
applying back strengthening and cruciform anterior spi-
nal hyperextension brace [6]. In this study, we present a 
retrospective data collection and comparative analysis 
of clinical indices, in 9 cases of rehabilitation treatment, 
that comprised back extensor strengthening exercise, 
core muscle exercise, and back pack wearing in Parkin-
son’s disease patients with camptocormia. Through this 
study, we aim to provide a rationale for further investiga-
tion and application of conservative treatment.
MATERIALS AND METHODS
Enrolled patients were diagnosed with Parkinson’s 
disease by expert neurologists and referred to the de-
partment of physical medicine and rehabilitation at our 
clinic, for postural instability, between March 2013 and 
August 2015. Camptocormia was diagnosed by an expert 
physiatrist and was differentiated from kyphosis by ly-
ing down in a recumbent position. Most authors define 
camptocormia as thoracolumbar flexion at least 45o when 
standing or walking. But this definition is known to be 
somewhat arbitrary and therefore we focused on limita-
tion of ADL and motor symptoms [9]. As a result, we de-
fined camptocormia as abnormal thoracolumbar flexion 
at least 5o, which resolves when the patient lies supine, 
and was accompanied by limitations of ADL and motor 
symptoms.
Nine patients (6 women and 3 men) included in the 
study had varying durations of Parkinson’s disease and 
camptocormia. All patients were taking anti-Parkinson’s 
medication, one patient had accompanying right pontine 
infarction, and three patients had a history of surgical 
treatment for spine deformity (Table 1). Dosage of anti-
Parkinson’s disease medication was constant during the 
follow-up period and deep brain stimulation (DBS) was 
not performed in all patients and freezing gait was not 
shown in all patients. We defined the duration of Par-
kinson’s disease as time from diagnosis of Parkinson’s 
disease and duration of camptocormia as time from ab-
normal thoracolumbar flexion. In cases #1, #2 and #4, the 
duration of camptocormia was longer than the duration 
of Parkinson’s disease. We examined for the presence of 
pathologic fracture or previous spinal operation history 
by X-ray evaluation before rehabilitation treatment.
The camptocormia flexion angles were measured by 
lateral view gross photograph [1] (Fig. 1). The three points 
used for measuring the flexion angle were midpoint of 
foot, crossing point between horizontal line from anterior 
superior iliac spine and vertical line from greater tro-
chanter and midpoint of auricle. Flexion angle was mea-
sured after 5 minutes of free ambulation. UPDRS II, III 
and modified Hoehn-Yahr staging were recorded at the 
beginning and at the end of treatment for each patient 
(Table 2).
Six inpatients received a 30-minute treatment twice a 
day for 5 weeks, for an average of 34 days (range, 23–44 
days). Treatment sessions were composed of 20 minutes 
of physiotherapy-core muscle strengthening exercise, 
pelvic tilting exercise, back extensor strengthening exer-
cise and bending side muscle stretching exercise, more 
focused on strengthening (Fig. 2A–2C). Then 10 minutes 
of treatment comprised ambulation while wearing a low-
slung backpack (Fig. 2D). The weight of the backpack 
started at 1.5 kg. Depending on tolerability, we increased 
the weight of the backpack until camptocormia was cor-
rected in a standing position. Patients were educated to 
wear the low-slung backpack at least 2 hours daily while 
ambulating. Anterior spinal hyperflexion brace was ap-
plied to 1 patient who was not able to tolerate the low-
slung backpack due to its weight (Fig. 2E).
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Fig. 1. Patient #7 before and after 
treatment. (A) She had an op-
erative treatment for kyphosis 
and lower back pain but showed 
camptocormia afterwards. (B) 
Lateral image before rehabilita-
tion treatment. (C) Lateral image 
after rehabilitation treatment.
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1 Pre 43 0 17 0 27 0 3 0
Post 43 17 27 3
2 Pre 77 62 10 3 16 5 3 0.5
Post 15 7 11 2.5
3 Pre 20 18 12 2 21 5 3 0.5
Post 2 10 16 2.5
4 Pre 24 4 23 9 43 7 4 1.5
Post 20 14 36 2.5
5 Pre 41 9 15 2 32 4 3 0.5
Post 32 13 28 2.5
6 Pre 6 12 11 5 40 6 3 0.5
Post -6 6 34 2.5
7 Pre 24 19 6 1 20 2 2.5 0.5
Post 5 5 18 2
8 Pre 49 47 13 1 31 3 3 0.5
Post 2 12 28 2.5
9 Pre 12 15 13 2 27 2 3 0.5
Post -3 11 25 2.5
Mean 20.667 2.778 3.778 0.556
p-valuea) 0.012* 0.011* 0.012* 0.007**
UPDRS, Unified Parkinson’s Disease Rating Scale.
*p<0.05 between pre- and post-treatment, **p<0.01 between pre- and post-treatment.
a)Wilcoxon signed-rank test.
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Three outpatients received treatment once a week 
for an average of 3 months, to undergo back exten-
sor strengthening exercise as well as backpack wearing 
treatment focusing on education for home exercise. The 
composition of treatment for these patients was not very 
different from the inpatients. Moreover, should be sched-
uled to visit the outpatient department to check physical 
status every 2–4 weeks for evaluation of compliance and 
determining the weight of the low-slung backpack.
All data were collected from medical charts record 
post-treatment. Clinical improvement was assessed by 
the change between pre- and post- rehabilitation treat-
ment flexion angle in the standing position (Dangle), 
UPDRS (DUPDRS), and modifided Hoenh-Yahr staging 
(Dmodifided Hoenh-Yahr staging). For statistical analysis 
Wilcoxon rank sum test was used and analyzed by SPSS 
software ver. 22.0 for Windows (IBM, Armonk, NY, USA).
RESULTS
Camptocormia was improved in all patients but one 
(case #1) in angle, UPDRS II and III, and modified Hoehn-
Yahr staging (Fig. 3). The most dramatic improvements 
were observed in case #2 for angle (Dangle=62o), and case 
#4 for UPDRS II (DUPRS II=9), UPDRS III (DUPDRS III=7), 
and modified Hoehn-Yahr staging (Dmodified Hoehn-
Yahr staging=1.5). In case #8, camptocormia initially 
came back with impaired walking when the lower slung 
backpack was removed, but at 3 months post-treatment 






Fig.  2.  Various modalities of 
conservative management for 
camptocormia. (A) Core muscle 
strengthening exercise. (B) Pelvic 
tilting exercise. (C) Back extensor 
strengthening exercise. (D) Low-
slung backpack. (E) Anterior spi-
nal hyperflexion brace.
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Therapeutic exercise was effective in improving angle 
(mean Dangle=20.667o), ADL (mean DUPRS II=2.778), 
and motor symptom index (mean DUPRS III=3.778; mean 
Dmodified Hoehn-Yahr staging=0.556) of Parkinson’s dis-
ease patients with camptocormia. Statistical significance 
was verified by Wilcoxon signed-rank test (p<0.05) (Table 
2). 
Case #4 patient showed a relatively small improvement 
in angle, but showed the largest improvement in UPDRS 
II & III and modified Hoehn-Yahr staging, suggesting that 
ADL and motor symptom evaluation is more important 
that just the angle itself in respect to treatment of camp-
tocormia in Parkinson’s disease.
DISCUSSION
Based on different hypotheses regarding the patho-
genesis of camptocormia, several treatment approaches 
have been suggested. The possible etiologies include the 
progression of Parkinson’s disease, dyskinetic movement 
due to Parkinsonism medication, Parkinsonism with dys-
tonia, and paraspinal myopathy. 
For camptocormia associated with Parkinson’s disease 
progression, high-dose dopaminergic medication such 
as levodopa has been used. However, in one study only 
20% of the subjects responded to levodopa treatment [8], 
while another study reported that high-dose levodopa 
may result in dyskinetic movement in Parkinson’s disease 
patients, suggesting that a reduced use of dopaminergics 
is recommended [2]. Some studies that have regarded 
camptocormia as a form of dystonia in Parkinson’s dis-
ease have utilized botulinum toxin injection in the rectus 
abdominis and iliopsoas muscles, but the efficacy of this 
treatment remains controversial [5,7,10]. 
Paraspinal myopathy that occurs due to or accompa-
nying Parkinson’s disease is another possible cause of 
camptocormia. In this regard, orthopedic surgical cor-
rection has been suggested as a possible treatment, while 
some beneficial effects of pallidotomy and deep brain 
stimulation have been reported. However, the efficacy of 
these treatments is still inconclusive [11-16]. An epide-
miological and clinical study by Tiple et al. [3] proposed 
that a history of vertebral surgery was a risk factor for the 
pathogenesis of camptocormia, while Upadhyaya et al. 
[17] reported that spinal surgery in Parkinson’s disease 
patients bears a high rate of postoperative complications, 
and that the presence of myelopathy or radiculopathy 
due to preoperative spinal stenosis must be considered. 
Among conservative treatment reports, Gerton et al. 
[18] reported the first case study using backpack-wearing 
to reduce the degree of flexion, and Schroeteler et al. 
[19] reported three cases where high frame walker with 
forearm support was used to improve back pain and 
walking distance. On the other hand, De Seze et al. [20] 
performed thoraco-pelvic anterior distraction orthosis 
and physiotherapy on 15 patients, which resulted in in-
creased lumbar lordosis, reduced pain, and enhanced 
quality of life, and Ye et al. [6] reported one case showing 
that a cruciform anterior spinal hyperflexion device and 
back extension strengthening exercise, resolved ambula-
tory disability and flexion posture permanently.
While most camptocormia treatment studies have been 
case reports, Capecci et al. [21] conducted a single-blind, 
randomized controlled trial with 20 Parkinsonism pa-
tients with postural deformity. In their study, 7 patients 
in a tailored postural rehabilitation group and 6 patients 
with tailored postural rehabilitation treatment and Kine-
sio taping, showed improved measures of trunk posture 
sagittal and coronal angles, gait and balance, in accor-
dance with our study. Our study is somewhat different 
A B
Fig. 3. Patient #4 before and after treatment. She was 
educated for home exercise at the outpatient clinic. After 
4 weeks of home exercise and low-slung backpack treat-
ment, she showed improvement of camptocormia. (A) 
Lateral image before rehabilitation treatment. (B) Lateral 
image after rehabilitation treatment.
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in that Capecci et al. [21] focused on tactile stimulation, 
stretching and postural re-education rather than back ex-
tensor strengthening exercise. 
In the present study, our case #1 patient did not show 
improvement in camptocormia after conservative treat-
ment. Previously Asahi et al. [1] have reported that bilat-
eral subthalamic deep brain stimulation was not effective 
in patients with paraspinal muscle degeneration, which 
was also found in case #1 patient as determined by lum-
bar spine magnetic resonance imaging (Fig. 4). In ad-
dition, Schulz-Schaeffer et al. [22] found that myopathy 
develops when secondary changes such as intrafascicular 
fibrosis and fatty degeneration progresses over time, pro-
posing a hypothesis that the timing of neurostimulation 
following camptocormia is the most important factor in 
the beneficial effect of treatments, yielding an explana-
tion for the negative result of case #1 patient. In contrast, 
lumbar spine magnetic resonance imaging of cases #4, 
#5, and #7 patients did not show paraspinal muscle de-
generation. However, it is controversial whether such 
fatty degeneration is a part of general aging process or a 
pathologic process due to Parkinson’s disease. 
From current literature, the pathophysiology of camp-
tocormia is not clear, therefore, whether it is due to 
Parkinson’s disease progression or simply occurs more 
frequently in individuals with progressive back muscle 
atrophy is questionable. 
There are several limitations in this study. First, we 
conducted X-ray evaluation only pre-rehabilitation. We 
could set other more objective points for measuring flex-
ion angles if we conducted post-rehabilitation treatment 
X-rays for all patients in exact lateral aspect. Second, 
comorbidities such as musculoskeletal problems and 
related pain that can affect gait endurance were not thor-
oughly evaluated. 
The advantage of rehabilitation treatment in campto-
cormia as presented in this study is that it is cost-effective 
and sustainable during follow-up periods (2–26 months), 
when in cooperation with the patient. Finally, continuous 
follow-up of treatment results and possible aggravations 
is easier, compared to surgical treatment.
In order to verify the efficacy of rehabilitation treatment 
for camptocormia, objective standards for determining 
treatment efficacy are desperately needed. Rather than 
relying on the patient’s subjective assessment of improve-
ment in their symptoms, an objective standard needs to 
be established. Currently, visual analog scales score, gait 
endurance, static vertebral angle, and subjective con-
tentment are available to assess conservative treatment 
results. However, problems arise due to the difficulty of 
defining objective standards. Some of our patients do 
not present signs of camptocormia before walking, but 
once they start walking the kyphotic angle increases (Fig. 
5). Therefore, it is challenging to determine an objective 
time point to measure the kyphotic angle. In addition, 
Fig. 4. Lumbar spine magnetic resonance imaging of pa-
tient #1. The arrows indicate atrophic change of paraspi-
nal muscle in magnetic resonance imaging T2 image of 
patient #1.
Fig. 5. Increased angle of camptocormia during ambula-
tion of patient #9. (A) At the beginning, angle of camp-
tocormia is smaller. (B) After 10 minutes of gait, angle of 
camptocormia increased.
A B
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gait endurance reduces as the kyphotic angle increases 
with walking. However, such gait endurance varies from 
patient to patient, and in most cases, within ten minutes 
of walking the kyphotic posture is so exacerbated to the 
extent the patient is not able to walk anymore, that prac-
tical measurement is difficult. Also in the case of static 
angle change, there is no definitive anatomical landmark 
or standards in frontal or lateral pictures such that com-
parative analysis can easily be influenced by the investi-
gator’s opinion [1,21]. 
In conclusion, it is not known whether camptocormia 
in Parkinson’s disease is a clinical characteristic of Par-
kinson’s disease or a comorbidity due to aging. No surgi-
cal treatment protocol is available. In this study, thera-
peutic exercise has been tested and shown to improve 
ADL and motor symptoms present in Parkinson’s disease 
with camptocormia. Therefore, we suggest that conserva-
tive treatments such as backpack-wearing or back exten-
sor strengthening exercise should be used as the first ap-
proach, rather than invasive methods such as orthopedic 
surgery or bilateral subthalamic deep brain stimulation. 
In the future, a conservative treatment study with a larger 
group of patients is needed. 
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